Apr 21 2012
Standard Register (NYSE: SR) today announced its financial results for
the first quarter 2012. The Company reported revenue of $157.6 million
and a net loss of $5.1 million, or $0.18 per share. The results compare
to prior year revenue of $164.9 million and net income of $0.4 million,
or $0.01 per diluted share. Non-GAAP net income, adjusted for pension
loss amortization, pension settlement, restructuring, and deferred tax
valuation allowances was $1.9 million, or $0.06 per share, for the first
quarter of 2012 as compared to non-GAAP net income of $4.1 million, or
$0.14 per diluted share for the same period in 2011.
\
"We saw significant positive activity in the first quarter of 2012 as
Healthcare, Financial Services and Commercial Markets business units
grew Core solutions during the period. Combined with the on-schedule
implementation of our restructuring plan, this gives us good momentum.
While revenue was down overall from the year-ago quarter, we have a
strong current ratio of 1.9, adequate liquidity for operations and
expect to end 2012 with positive cash flow of at least $5 million," said
Joseph P. Morgan, Jr., president and chief executive officer.
Morgan continued, "We continue to make the necessary investments to
transform Standard Register into a provider of solutions that enable our
customers to align their brand communications with their corporate
priorities and standards. We are seeing our portfolio evolve and winning
new business that demonstrates good progress."
Results
Total revenues declined 4 percent to $157.6 million in the first quarter
versus $164.9 million in the prior year. Core priority growth solutions
revenues grew 3 percent during the quarter whereas Legacy products, such
as business forms and transactional labels, across all business units
declined by 9 percent.
Healthcare revenue declined 6 percent to $57.0 million in the first
quarter compared to $60.7 million in the prior year. Core solutions grew
by 5 percent driven by the acquisition of 100 percent of the ownership
interests in iMedConsent, LLC (dba Dialog Medical), which the Company
completed in the third quarter 2011, as well as new business and organic
growth in patient communications and patient identification and safety
solutions. Healthcare technology solutions sales grew 15 percent in the
quarter. Legacy products, primarily clinical documents and
administrative forms sales declined 12 percent as customers advanced
implementation of Electronic Medical Records (EMR) initiatives.
Financial Services revenue showed slight growth at $43.5 million in the
first quarter compared to $43.3 million in the prior year. The Company
began recognizing revenue from a new Core solutions customer and saw
growth in existing smaller customers. These sales served to offset the
loss of Legacy and Core solutions from a customer that is expected to
impact revenues in this segment by $18 - $20 million this year.
The Commercial Markets business unit experienced a 7 percent decline to
$37.6 million for the quarter from $40.3 million in the prior year
driven primarily by losses in Legacy products, which represent a
disproportionate amount of sales in the business unit. Momentum in Core
marketing solutions is expected to grow during the remainder of 2012.
The Industrial business unit generated $19.5 million in revenue or a
decline of 5 percent for the quarter as compared to $20.6 million a year
ago, driven by pricing pressure and weak demand from HVAC customers, and
a 49% decrease from the year-ago quarter for in-mold labeling sales
related to timing.
Gross margin as a percent of revenue decreased to 30.6 percent for the
current year quarter from 32.4 percent in the prior year quarter.
Pricing pressures, particularly in Legacy transactional forms and
labels, declines in volume and material cost increases all contributed
to the change. Selling, general and administrative expenses, excluding
pension and restructuring, declined $1.8 million to $44.4 million, or
28.2 percent of revenue, relative to $46.2 million and 28.0 percent for
the prior year quarter.
For the first quarter 2012, capital expenditures were $0.7 million,
pension funding contributions were $7.0 million and Non-GAAP cash flow
on a net debt basis was $3.4 million. For 2012, the Company is planning
to spend $9 - 11 million in capital expenditures to further support its
Core growth solutions offering and to contribute at least the minimum
requirement of $27.0 million for Pension funding.